Initially, NPC patients with a plasma Exo-PD-L1 expression higher or lower than 3.5 pg/mL did not show significant differences in ORR (overall response rate), PFS (progressive-free survival), and OS (overall survival). Here, CD274 is linked to nasopharyngeal carcinoma.